Log in

Relevant bibliographies by topics / Anti-tumor agent / Books

To see the other types of publications on this topic, follow the link: Anti-tumor agent.

Books on the topic 'Anti-tumor agent'

Author: Grafiati

Published: 3 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 19 books for your research on the topic 'Anti-tumor agent.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Reznik, Samuel Kaye. Methodological Innovations in Polyketide Synthesis and their Application toward the Scalable Synthesis of Anti-Tumor Agent Spongistatin 1. [publisher not identified], 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

M, Muggia Franco, and Rozencweig Marcel, eds. Clinical evaluation of anti-tumor therapy. Nijhoff, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Altmann, K. H., G. Höfle, R. Müller, J. Mulzer, and K. Prantz. The Epothilones: An Outstanding Family of Anti-Tumor Agents. Springer Vienna, 2009. http://dx.doi.org/10.1007/978-3-211-78207-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Li, Shiyou. Camptotheca acuminata decaisne, Xi shu [Hsi shu] (Chinese Happytree): A promising anti-tumor and anti-viral tree for the 21st century. Tucker Center, College of Forestry, Stephen F. Austin State University, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Mulzer, Johann H. The Epothilones: An Outstanding Family of Anti-Tumor Agents. Springer, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

J, Smith Paul, and Eddy W. Yue. Inhibitors of Cyclin-Dependent Kinases As Anti-tumor Agents. Taylor & Francis Group, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

J, Smith Paul, and Eddy W. Yue. Inhibitors of Cyclin-Dependent Kinases As Anti-Tumor Agents. Taylor & Francis Group, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Adair, Kent T., and Shiyou Li. Camptotheca Acuminata Decaisne, XI Shu, a Promising Anti-Tumor and Anti-Viral Tree for the Twenty-First Century (Chinese Happytree : a Promising Anti-Tumor and Anti-Viral Tree for the 21st Century). Stephen F. Austin State University, School of, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Smith, Paul J. Inhibitors of Cyclin-Dependent Kinases as Anti-Tumor Agents (Enzyme Inhibitors). CRC Press, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

(Editor), Franco M. Muggia, and Marcel Rozencweig (Editor), eds. Clinical Evaluation of Anti-Tumor Therapy (Developments in Oncology). Springer, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Lukiewicz, Stanislaw, and Jay L. Zweier. Nitric Oxide in Transplant Rejection and Anti-Tumor Defense. Springer London, Limited, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

(Editor), Paul J. Smith, and Eddy W. Yue (Editor), eds. Inhibitors of Cyclin-dependent Kinases as Anti-tumor Agents (Crc Enzyme Inhibitors). CRC, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Josephs, Debra H., Heather J. Bax, Giulia Pellizzari, James F. Spicer, Ana Montes, and Sophia N. Karagiannis. Antibody Therapeutics for Ovarian Carcinoma and Translation to the Clinic. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0001.

Full text

Abstract:

Despite improvements over the past decade in the treatment of ovarian cancer, many patients are at risk of recurrent disease and emerging drug resistance. The increased selectivity and reduced toxicity of molecularly targeted anti-cancer agents renders them attractive for development in ovarian cancer, and monoclonal antibodies targeting ovarian cancer-specific tumor antigens represent the largest such group investigated in this clinical setting. This chapter describes examples of monoclonal antibodies clinically evaluated for efficacy in ovarian cancer. These agents recognize molecular target

APA, Harvard, Vancouver, ISO, and other styles

14

Lukiewicz, Stanislaw, and Jay L. Zweier. Nitric Oxide in Transplant Rejection and Anti-Tumor Defense. Springer London, Limited, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Kinghorn, A. Douglas, Rolf Müller, Karl-Heinz Altmann, Johann H. Mulzer, Gerhard Höfle, and Kathrin Prantz. The Epothilones : An Outstanding Family of Anti-Tumor Agents: From Soil to the Clinic. Springer, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

(Editor), Jeffrey M. Weinberg, and Robin Buchholz (Editor), eds. TNF-alpha Inhibitors (Milestones in Drug Therapy). Birkhäuser Basel, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Drerup, Justin M., Curtis A. Clark, and Tyler J. Curiel. Clinical Trials of Ovarian Cancer Immunotherapy and Future Directions. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0013.

Full text

Abstract:

Ovarian cancer (OC) is an immunogenic tumor and among the first where measures of anti-tumor immunity correlated with improved survival. Thus, immunotherapy could be a viable OC treatment modality. Nonetheless, clinical OC immunotherapy trials have demonstrated only modest successes at best, and there is currently no Food and Drug Administration (FDA)approved OC immune therapy despite recent successes in other carcinomas and lymphomas and FDA-approved immunotherapy agents for them. New data suggest specific impediments to effective de novo and treatment-induced anti-OC immunity and support the

APA, Harvard, Vancouver, ISO, and other styles

18

The Epothilones: An Outstanding Family of Anti-Tumor Agents: From Soil to the Clinic (Fortschritte der Chemie organischer Naturstoffe Progress in the Chemistry of Organic Natural Products Book 90). Springer, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Cattaneo, Giuditta Filippini. A new flow cytometric P53 detection method as start point to study the effects of classical anti-tumor agents and of two endogenous substances (norepinephrine and lysophosphatidylcholine) on tumoral cell growth. 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!